Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Cash & Short-Term Investments

$1.62B

Quarterly · Period ending: Jun 30, 2026 · USD

BIO Cash & Short-Term Investments

Latest reported$1.62Bperiod endingJun 30, 2026

BIO Quarterly Cash & Short-Term Investments ($6.00M → $1.62B)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

BIO cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Cash & Short-Term Investments — Quarterly (USD)
Period ending	Cash & Short-Term Investments (USD)
Jun 30, 2026	1,618,500,000
Mar 31, 2026	1,564,700,000
Dec 31, 2025	1,542,700,000
Sep 30, 2025	1,420,600,000
Jun 30, 2025	1,373,800,000
Mar 31, 2025	1,660,400,000
Dec 31, 2024	1,664,500,000
Sep 30, 2024	1,622,458,000
Jun 30, 2024	1,616,106,000
Mar 31, 2024	1,645,674,000
Dec 31, 2023	1,607,142,000
Sep 30, 2023	1,758,993,000
Jun 30, 2023	1,722,686,000
Mar 31, 2023	1,851,453,000
Dec 31, 2022	1,790,672,000
Sep 30, 2022	1,850,123,000
Jun 30, 2022	1,967,659,000
Mar 31, 2022	2,073,479,000
Dec 31, 2021	869,918,000
Sep 30, 2021	1,337,098,000
Jun 30, 2021	1,161,398,000
Mar 31, 2021	1,019,868,000
Dec 31, 2020	991,118,000
Sep 30, 2020	1,154,427,000
Jun 30, 2020	1,031,810,000
Mar 31, 2020	1,036,701,000
Dec 31, 2019	1,114,645,000
Sep 30, 2019	979,248,000
Jun 30, 2019	981,856,000
Mar 31, 2019	858,989,000
Dec 31, 2018	844,796,000
Sep 30, 2018	860,570,000
Jun 30, 2018	818,247,000
Mar 31, 2018	762,933,000
Dec 31, 2017	754,978,000
Sep 30, 2017	716,457,000
Jun 30, 2017	712,852,000
Mar 31, 2017	674,075,000
Dec 31, 2016	839,440,000
Sep 30, 2016	806,116,000
Jun 30, 2016	791,595,000
Mar 31, 2016	748,660,000
Dec 31, 2015	786,267,000
Sep 30, 2015	786,078,000
Jun 30, 2015	727,646,000
Mar 31, 2015	710,686,000
Dec 31, 2014	697,635,000
Sep 30, 2014	702,578,000
Jun 30, 2014	647,578,000
Mar 31, 2014	641,333,000
Dec 31, 2013	608,920,000
Sep 30, 2013	561,820,000
Jun 30, 2013	834,432,000
Mar 31, 2013	836,832,000
Dec 31, 2012	921,073,000
Sep 30, 2012	853,621,000
Jun 30, 2012	835,257,000
Mar 31, 2012	807,050,000
Dec 31, 2011	813,115,000
Sep 30, 2011	910,202,000
Jun 30, 2011	886,248,000
Mar 31, 2011	791,436,000
Dec 31, 2010	1,025,187,000
Sep 30, 2010	738,000,000
Jun 30, 2010	717,709,000
Mar 31, 2010	691,782,000
Dec 31, 2009	744,814,000
Sep 30, 2009	642,109,000
Jun 30, 2009	563,359,000
Mar 31, 2009	222,830,000
Dec 31, 2008	243,474,000
Sep 30, 2008	234,312,000
Jun 30, 2008	227,155,000
Mar 31, 2008	177,123,000
Dec 31, 2007	223,741,000
Sep 30, 2007	543,405,000
Jun 30, 2007	502,866,000
Mar 31, 2007	471,732,000
Dec 31, 2006	488,080,000
Sep 30, 2006	481,573,000
Jun 30, 2006	433,965,000
Mar 31, 2006	394,763,000
Dec 31, 2005	413,059,000
Sep 30, 2005	358,502,000
Jun 30, 2005	343,384,000
Mar 31, 2005	383,805,000
Dec 31, 2004	361,633,000
Sep 30, 2004	125,154,000
Jun 30, 2004	155,329,000
Mar 31, 2004	141,548,000
Dec 31, 2003	148,642,000
Sep 30, 2003	140,748,000
Jun 30, 2003	28,828,000
Mar 31, 2003	25,223,000
Dec 31, 2002	27,733,000
Sep 30, 2002	39,250,000
Jun 30, 2002	25,655,000
Mar 31, 2002	44,946,000
Dec 31, 2001	47,129,000
Sep 30, 2001	32,326,000